The role of Aldosterone in the pathogenesis of Diabetes.

The role of Aldosterone in the pathogenesis of Diabetes. - The role of Aldosterone in the pathogenesis of Diabetes.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017666

Enrollment

Registered

2015-05-25

Start date

2015-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Aldosteronism

Interventions

Surgical resection if PA is lateral adrenal tumor Eplerenone administration if PA is bilateral hyperplasia (50mg Tablet 1T1* M)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary Aldosteronism

Exclusion criteria

Exclusion criteria: Glucocorticoid-remediable aldosteronism

Design outcomes

Primary

Measure	Time frame
1)Insulin secretion 2)Inflamatory cytokine(IL-6,TNF) 3)Glucagon, GLP-1	—

Countries

Japan

Contacts

Public ContactTatsuya Kondo

Faculty of Life Sciences, Kumamoto University Metabolic Medicine

t-kondo@gpo.kumamoto-u.ac.jp+81-96-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026